Indivior (INDV) Stock Discussion | Share discussion

Indivior

Indivior PLC, a specialty pharmaceutical company, develops therapies for the chronic diseases of addiction and related mental health disorders worldwide.

Industry: Pharmaceuticals & Biotechnology

Ticker	Exchange	ISIN
$INDV	LSE Main Market	GB00BRS65X63

Recent news

Carnival Net Income dropped on 442% and Revenue dropped on 73.1%

Unisys Corp reports 4,465% Net Income growth in 2020 while 31.3% Revenue decline

Northamber Net Income surged on 1,523%

International Bus Mach Corp reports 40.7% Net Income decline in 2020 and 3.2 pp EBITDA Margin decline from 20.7% to 17.5%

Blue Prism Group plc revenue surged on 40% and EBITDA Margin surged on 28.9 pp from -78.3% to -49.4%

Tui Ag EBITDA dropped on 220% and Revenue dropped on 58.0%

Zytronic Net Income dropped on 111% and EBITDA Margin dropped on 15.0 pp from 20.6% to 5.6%

Image Scan Hldgs revenue surged on 47.3% and EBITDA Margin surged on 21.0 pp from -16.0% to 5.0%

Oxford Metrics Net Income dropped on 61.6% and Revenue dropped on 14.3%

I-Nexus Global Plc revenue dropped on 14.3%

Twit about INDV stock

Share your investment idea or question on Indivior stock:

Latest twits on Indivior (INDV)

No twits yet. Be the first to post!

Have a question about INDV? Ask and other investors will be eager to help you.

Have an idea about INDV? Share it with other investors.

Indivior news

13 Feb 2020 Indivior reports 51.3% Net Income decline in 2019 and 21.9% Revenue decline

14 Feb 2019 Indivior Net Income jumped on 374% and EBITDA Margin surged on 14.2 pp from 18.8% to 33.0%

Indivior stock price chart

Indivior financials

mln. $	FY2013	FY2014	FY2015

Revenue	1,216	1,115	1,014
EBITDA	723.0	588.0	378.0
Net income	489.0	403.0	228.0
CAPEX	3.000	0.000	27.000
Debt	0.000	736.0	605.0
Cash	7.000	331.0	467.0

Indivior news

13 Feb 2020 Indivior reports 51.3% Net Income decline in 2019 and 21.9% Revenue decline

14 Feb 2019 Indivior Net Income jumped on 374% and EBITDA Margin surged on 14.2 pp from 18.8% to 33.0%

About Indivior

Indivior PLC, a specialty pharmaceutical company, develops therapies for the chronic diseases of addiction and related mental health disorders worldwide. The company